Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Gourley

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
The Lancet. Psychiatry|March 17, 2018
Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trialsAmy Mulick, Jane Walker, Stephen Puntis, et al.
Journal of Psychosomatic Research|January 19, 2019
Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trialsAmy Mulick, Jane Walker, Stephen Puntis, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2003
A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancerCharlie Gourley, James Cassidy, Chris Edwards, et al.
The Lancet. Oncology|September 2, 2014
Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancerJane Walker, Christian Holm Hansen, Paul Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2019
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer TherapyCharlie Gourley, Judith Balmaña, Jonathan A Ledermann, et al.
Lancet (London, England)|September 2, 2014
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trialMichael Sharpe, Jane Walker, Christian Holm Hansen, et al.
Gynecologic Oncology|September 26, 2025
The role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort studySahana Somasegar, Jiaqi Zhang, Christina Fotopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2024
Whole exome sequencing reveals diverse genomic relatedness between paired concurrent endometrial and ovarian carcinomasEmily Southworth, John P Thomson, Ian Croy, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
The Lancet. Psychiatry|March 17, 2018
Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trialsAmy Mulick, Jane Walker, Stephen Puntis, et al.
Journal of Psychosomatic Research|January 19, 2019
Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trialsAmy Mulick, Jane Walker, Stephen Puntis, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2003
A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancerCharlie Gourley, James Cassidy, Chris Edwards, et al.
The Lancet. Oncology|September 2, 2014
Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancerJane Walker, Christian Holm Hansen, Paul Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2019
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer TherapyCharlie Gourley, Judith Balmaña, Jonathan A Ledermann, et al.
Lancet (London, England)|September 2, 2014
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trialMichael Sharpe, Jane Walker, Christian Holm Hansen, et al.
Gynecologic Oncology|September 26, 2025
The role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort studySahana Somasegar, Jiaqi Zhang, Christina Fotopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2024
Whole exome sequencing reveals diverse genomic relatedness between paired concurrent endometrial and ovarian carcinomasEmily Southworth, John P Thomson, Ian Croy, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Pageof 15